Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada · Delayed Price · Currency is CAD 13.05
-0.45 (-3.33%)
Oct 30, 2026, 4:00 PM EDT
Cipher Pharmaceuticals Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 332 | 382 | 366 | 133 | 96 | 46 | |
Market Cap Growth | -10.46% | 4.29% | 175.35% | 37.94% | 107.72% | 84.74% |
Enterprise Value | 319 | 389 | 409 | 77 | 59 | 27 |
Last Close Price | 13.50 | 15.06 | 14.32 | 5.54 | 3.84 | 1.77 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.18 | 10.20 | 22.06 | 4.94 | 2.68 | 4.73 |
Forward PE | 11.55 | 18.41 | 15.93 | 11.11 | 8.77 | 3.95 |
PS Ratio | 4.87 | 5.53 | 7.63 | 4.76 | 3.45 | 1.67 |
PB Ratio | 1.76 | 2.21 | 2.49 | 1.25 | 1.11 | 0.94 |
P/TBV Ratio | 4.79 | 7.58 | 41.47 | 1.60 | 1.56 | 1.88 |
P/FCF Ratio | 8.94 | 9.39 | - | 6.36 | 6.70 | 2.66 |
P/OCF Ratio | 8.93 | 9.38 | 13.03 | 6.30 | 6.65 | 2.66 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.69 | 5.63 | 8.51 | 2.74 | 2.12 | 0.96 |
EV/EBITDA Ratio | 8.70 | 11.92 | 24.29 | 5.07 | 3.67 | 1.54 |
EV/EBIT Ratio | 11.80 | 16.83 | 36.19 | 5.63 | 3.97 | 1.62 |
EV/FCF Ratio | 8.62 | 9.56 | - | 3.66 | 4.12 | 1.53 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.04 | 0.40 | 0.00 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.01 | 0.23 | 3.42 | 0.03 | 0.04 | 0.04 |
Debt / FCF Ratio | 0.01 | 0.19 | - | 0.02 | 0.04 | 0.04 |
Net Debt / Equity Ratio | -0.06 | -0.02 | 0.22 | -0.49 | -0.44 | -0.51 |
Net Debt / EBITDA Ratio | -0.33 | -0.08 | 1.95 | -3.45 | -2.38 | -1.47 |
Net Debt / FCF Ratio | -0.32 | -0.07 | -0.38 | -2.49 | -2.67 | -1.45 |
Asset Turnover | 0.32 | 0.32 | 0.27 | 0.27 | 0.33 | 0.46 |
Inventory Turnover | 1.25 | 1.44 | 2.11 | 1.59 | 2.10 | 2.90 |
Quick Ratio | 1.09 | 0.75 | 1.60 | 8.55 | 3.80 | 2.21 |
Current Ratio | 1.59 | 1.12 | 1.94 | 9.19 | 4.07 | 2.38 |
Return on Equity (ROE) | 23.50% | 23.91% | 12.63% | 28.19% | 51.73% | 21.69% |
Return on Assets (ROA) | 7.97% | 6.61% | 3.95% | 8.06% | 11.01% | 17.02% |
Return on Invested Capital (ROIC) | 15.46% | 13.53% | 9.45% | 26.86% | 40.52% | 41.44% |
Return on Capital Employed (ROCE) | 14.40% | 12.80% | 5.50% | 12.80% | 17.20% | 33.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 12.22% | 9.80% | 4.53% | 20.23% | 37.37% | 21.14% |
FCF Yield | 11.18% | 10.66% | -23.75% | 15.73% | 14.93% | 37.64% |
Buyback Yield / Dilution | 1.02% | -3.04% | 0.79% | 1.46% | 3.84% | 1.96% |